Built for Lunovus

The command center for scaling eyecare revenue

One dashboard to track practice enrollments, patient adherence, Doc2Home performance, and platform growth. Built by Polsia for the team that turned supplement compliance into a business model.

91%
Patient adherence rate
$9/mo
Recurring revenue per patient
20+yr
Physician-led innovation
40+yr
Software development heritage

Everything Lunovus needs to grow, in one place

📊

Revenue Intelligence

Track Doc2Home performance, practice enrollments, and per-patient revenue across the entire Lunovus360 ecosystem in real time.

🎯

Practice Growth Engine

Identify high-potential eye care practices, automate outreach, and monitor the enrollment pipeline from first contact to active subscriber.

🤖

AI Operations

Autonomous agents handle competitive research, market analysis, and daily reporting. Polsia works on Lunovus growth around the clock.

📦

Fulfillment Visibility

Monitor PrivateFill adherence rates, shipping performance, and reorder patterns to keep the 91% compliance rate climbing.

Doctors build for doctors. Software amplifies the mission.

Lunovus was founded by physicians who understood a simple truth: the best patient outcomes come when compliance is effortless. Doc2Home eliminated the guesswork of supplement adherence by delivering exactly what patients need, on schedule, to their door.

LunovusOS exists to accelerate that flywheel. More practices enrolled means more patients served, which means more recurring revenue reinvested into better products and better technology.

Zero inventory
Practices earn commissions without stocking a single product
FDA inspected
GMP-compliant, US-manufactured supplements
Since 2004
Two decades of physician-owned eye care innovation

Where compliance meets commerce

Lunovus isn't just selling supplements. It's building the infrastructure that lets every independent eye care practice generate predictable, recurring revenue while delivering better patient outcomes. LunovusOS is the operating system powering that future.